Phosphate Binders in CKD: ‟New Kids on the Block”

Q: What type of study is this?

This is a Literature Review study.

Muhammad Afzal; Shafeeq Cheema

doi:10.53778/pjkd31089

February 5, 2021Pakistan Journal of Kidney Diseases

Phosphate Binders in CKD: ‟New Kids on the Block”

View at Publisher

Ask AI

Bookmark

Share

Key Points

Effective phosphate control is crucial for chronic kidney disease management and improves patient outcomes.
Patients with chronic kidney disease often experience high phosphate levels, leading to increased morbidity and mortality.
The review presents both older and newer phosphate binder medications that are key to managing hyperphosphatemia in CKD.
Understanding the various phosphate binders available can help tailor treatment approaches in chronic kidney disease management.

Implication

Review highlights phosphate binder options for managing hyperphosphatemia in CKD patients, suggesting potential improvements.

Abstract

Phosphate control is essential component of dietary and medical management of chronic kidney disease (CKD) patients. Hyperphosphatemia has a significant effect on morbidity and mortality of CKD patients. This review takes us through the different older and newer medications available for management of hyperphosphatemia.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Afzal et al. (2021) studied this question.

synapsesocial.com/papers/68e7103b90569dd607ee6c43 https://doi.org/10.53778/pjkd31089

View at Publisher

Ask AI

Bookmark

Share

Phosphate Binders in CKD: ‟New Kids on the Block”

Key Points

Implication

Abstract

Discussion

Cite This Study

Phosphate Binders in CKD: ‟New Kids on the Block”

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading